Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712770 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'PharmaVitae : Wyeth' returned 15 results - Page 1 of 1

  Sort by   
  Sorted by Rank Top-Bottom

Wyeth: PharmaVitae Profile  
Datamonitor, March 2009, Pages: 159
SUMMARY Key findings Prescription pharmaceutical sales performance, 2001-13 Financial performance, 2001-13 Wyeth: PharmaVitae forecasts at a glance Strategic insight Wyeth to be acquired by Pfizer


Wyeth: PharmaVitae Model  
Datamonitor, Jan 2009
and pipeline data Wyeth: PharmaVitae Model


Pfizer Inc.: PharmaVitae Profile  
Datamonitor, Nov 2010, Pages: 122
-2011 Executive Summary Key findings Prescription pharmaceutical sales and growth rate performance, 2003– Financial performance, 2003– Pfizer: PharmaVitae forecasts at a glance Strategic


Genzyme Corporation: PharmaVitae Profile  
Datamonitor, Aug 2010, Pages: 98
Genentech, Inc. Genzyme Corporation Gilead Sciences, Inc. IMS Health Wyeth Genzyme Corporation: PharmaVitae Profile


Amgen Inc.: PharmaVitae Profile  
Datamonitor, June 2010, Pages: 105
Company, Inc. Johnson & Johnson Kirin Brewery Holdings Company, Limited Medicines Company, The OPG Groep Pfizer Inc Wyeth Amgen Inc.: PharmaVitae Profile


Abbott Laboratories: PharmaVitae Profile  
Datamonitor, May 2011, Pages: 95
Company, The Merck & Co., Inc. Merck KGaA Novartis AG Pfizer Inc Schering-Plough Corporation Solvay Group The Depository Trust & Clearing Corporation Wyeth Abbott Laboratories: PharmaVitae Profile


Takeda Pharmaceutical Co., Ltd: PharmaVitae Profile  
Datamonitor, Oct 2010, Pages: 98
Pharmaceutical Products, Inc. The Depository Trust & Clearing Corporation Wyeth Takeda Pharmaceutical Co., Ltd: PharmaVitae Profile


Bristol-Myers Squibb Co.: PharmaVitae Profile  
Datamonitor, March 2011, Pages: 84
an imminent wave of generic compeitition. - Assess what makes BMS a model biopharma company and why its newfound focus could lead to the industry's next megamerger ABOUT THIS PROFILE - PharmaVitae Explorer


Bayer Schering Pharma AG: PharmaVitae Profile  
Datamonitor, June 2010, Pages: 116
enhanced the company's HealthCare division -Assess how an increased healthcare focus and merger-related synergies will drive an increase in operating profit Chapter 1 About this profile PharmaVitae


Big Pharma M&A Analysis to 2012 - Surveying the Growth Rate Landscape  
Datamonitor, Aug 2008, Pages: 244
31 Introduction to the PharmaVitae Rx pharma universe 32 PharmaVitae universe company sales analysis 34 PharmaVitae universe company Rx sales, 2007 34 PharmaVitae universe company absolute Rx sales


Key Companies: Depression - Leading players must adapt to remain competitive  
Datamonitor, Aug 2011, Pages: 40
reports APPENDIX PharmaVitae Explorer database Contributing experts Conferences attended Report methodology Key Companies: Depression - Leading players must adapt to remain competitive


Solvay S.A.: PharmaVitae Profile  
Datamonitor, March 2009, Pages: 134
., Inc. Nektar Therapeutics Nycomed International Management GmbH Pfizer Inc Safety Insurance Group, Inc. Sepracor Inc. Servier Solvay Group Wyeth Solvay S.A.: PharmaVitae Profile


Big Pharma Performance Before, During and Beyond the Global Recession  
Datamonitor, Nov 2009, Pages: 75
and future analysis Cross-sector analysis Pharma analysis Data sources Ex-pharma data Pharma data PharmaVitae Explorer database Re-creating analysis from this report using PharmaVitae Explorer queries


Big Pharma Mega-Mergers 1995-2014  
Datamonitor, Dec 2009, Pages: 114
-2014 Chapter 1 Introduction Scope of analysis Methodology Company coverage Data sources Re-creating analysis from this report using PharmaVitae Explorer queries Further reading Chapter 2 Executive


Monoclonal Antibodies Report: 2008 Update  
Datamonitor, June 2008, Pages: 363
changes 8 Table 2: PharmaVitae company coverage by peer set 11 Table 3: Molecule type definitions 16 Table 4: General characteristics of small molecule drugs vs. biologics 18 Table 5: Prescription


Results:  First -   Prev -   1 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds